Perrin-Terrin, A., Pathak, A., & Lapeyre-Mestre, M. (2011). QT interval prolongation: Prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundamental & Clinical Pharmacology, 25(4), 503. https://doi.org/10.1111/j.1472-8206.2010.00871.x
Chicago Style (17th ed.) CitationPerrin-Terrin, Aurélie, Atul Pathak, and Maryse Lapeyre-Mestre. "QT Interval Prolongation: Prevalence, Risk Factors and Pharmacovigilance Data Among Methadone-treated Patients in France." Fundamental & Clinical Pharmacology 25, no. 4 (2011): 503. https://doi.org/10.1111/j.1472-8206.2010.00871.x.
MLA (9th ed.) CitationPerrin-Terrin, Aurélie, et al. "QT Interval Prolongation: Prevalence, Risk Factors and Pharmacovigilance Data Among Methadone-treated Patients in France." Fundamental & Clinical Pharmacology, vol. 25, no. 4, 2011, p. 503, https://doi.org/10.1111/j.1472-8206.2010.00871.x.